1-Cyclopropyl-8-ethoxy-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

Catalog No. :
ACLMTY823
CAS No. :
112811-83-3
Molecular Formula :
C19H22FN3O4
Molecular Weight :
375.40

IUPAC Name:1-cyclopropyl-8-ethoxy-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

1-Cyclopropyl-8-ethoxy-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Cyclopropyl-8-ethoxy-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
IUPAC Name1-cyclopropyl-8-ethoxy-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
Molecular FormulaC19H22FN3O4
Molecular Weight375.40
SMILESO=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCNCC4)=C3OCC)C1=O)O
InChI KeyYKKIBHKSHPPCEQ-UHFFFAOYSA-N
Synonym3-Quinolinecarboxylic acid, 1-cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
CAS No.112811-83-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLMTY823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLMTY823 route product structure diagram
    ACLMTY823112811-83-3
Inquiry

2. ACLMTY823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACWJOX194 route compound structure diagram
    ACWJOX194143158-55-8 In Stock
  4. Then
  5. ACLMTY823 route product structure diagram
    ACLMTY823112811-83-3
Inquiry

Comments (0)